http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014137128-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate | 2013-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014137128-A |
| titleOfInvention | METHOD FOR TREATING INTESTINAL DISEASES WITH THE PRESENCE OF AT LEAST ONE INFLAMMATORY COMPONENT |
| abstract | 1. A medicine containing a combination of the first and second compositions for simultaneous, separate or sequential use for the treatment of intestinal disease with the presence of at least one inflammatory component and / or maintaining remission of the intestinal disease with the presence of at least one inflammatory component in a patient, where said first composition comprises at least one compound for treating said disease, wherein said second composition comprises: (1) a tablet core tissue containing: (a) budesonide in an amount effective to treat or maintain remission of an intestinal disease with the presence of at least one inflammatory component, (b) at least one lipophilic excipient, (c) at least one amphiphilic excipient; and (d) at least one hydrophilic filler; and (2) a coating on said tablet core, wherein said coating comprises a gastric juice resistant film. The medicament for use according to claim 1, wherein the first composition is administered to the patient before the second composition. The medicament for use according to claim 1, wherein the first composition is administered to the patient simultaneously with the second composition. The drug for use according to any one of paragraphs. 1-3, where the bowel disease with the presence of at least one inflammatory component is an inflammatory bowel disease, such as ulcerative colitis, Crohn's disease or ulcerative colitis with mild to moderate activity. The drug for use according to any one of paragraphs. 1-3, where bowel disease with the presence of at least one |
| priorityDate | 2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.